EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction

Camilla Hage, Erik Michaëlsson, Cecilia Linde, Erwan Donal, Jean-Claude Daubert, Li-Ming Gan, Lars H Lund

Circulation: Cardiovascular Genetics · 2017-01 · 10 (1)

DOI: 10.1161/circgenetics.116.001633 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Genetics, 2017-01. Verfasst von Camilla Hage und 6 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (C.H., C.L., L.H.L.); Department of Cardiology, Karolinska University…. Hauptthemen laut MEDLINE: Stroke Volume, Ventricular Function, Left. Die Arbeit wurde bisher 165-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background— Underlying mechanisms in heart failure (HF) with preserved ejection fraction remain unknown. We investigated cardiovascular plasma biomarkers in HF with preserved ejection fraction and their correlation to diastolic dysfunction, functional class, pathophysiological processes, and prognosis. Methods and Results— In 86 stable patients with HF and EF ≥45% in the Karolinska Rennes (KaRen) biomarker substudy, biomarkers were quantified by a multiplex immunoassay. Orthogonal projection to latent structures by partial least square analysis was performed on 87 biomarkers and 240 clinical variables, ranking biomarkers associated with New York Heart Association (NYHA) Functional class and the composite outcome (all-cause mortality and HF hospitalization). Biomarkers significantly correlated with outcome were analyzed by multivariable Cox regression and correlations with echocardiographic measurements performed. The orthogonal partial least square outcome-predicting biomarker pattern was run against the Ingenuity Pathway Analysis (IPA) database, containing annotated data from the public domain. The orthogonal partial least square analyses identified 32 biomarkers correlated with NYHA class and 28 predicting outcomes. Among outcome-predicting biomarkers, growth/differentiation factor-15 was the strongest and an additional 7 were also significant in Cox regression analyses when adjusted for age, sex, and N-terminal probrain natriuretic peptide: adrenomedullin (hazard ratio per log increase 2.53), agouti-related protein; (1.48), chitinase-3–like protein 1 (1.35), C–C motif chemokine 20 (1.35), fatty acid–binding protein (1.33), tumor necrosis factor receptor 1 (2.29), and TNF-related apoptosis-inducing ligand (0.34). Twenty-three of them correlated with diastolic dysfunction (E/e′) and 5 with left atrial volume index. The IPA suggested that increased inflammation, immune activation with decreased necrosis and apoptosis preceded poor outcome. Conclusions— In HF with preserved ejection fraction, novel biomarkers of inflammation predict HF severity and prognosis that may complement or even outperform traditional markers, such as N-terminal probrain natriuretic peptide. These findings lend support to a hypothesis implicating global systemic inflammation in HF with preserved ejection fraction. Clinical Trial Registration— URL: http://www.clinicaltrials.gov ; Unique identifier: NCT00774709.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stroke VolumeVentricular Function, LeftAgedAged, 80 and overBiomarkersDatabases, ProteinEchocardiographyFemaleFranceHeart FailureHumansInflammation MediatorsLeast-Squares AnalysisMaleMultivariate AnalysisPredictive Value of TestsPrognosisProportional Hazards ModelsProspective StudiesProteomicsRisk FactorsSeverity of Illness Index

Stichwörter der Autor:innen

apoptosisbiomarkersinflammationprognosisproteomics

Substanzen

BiomarkersInflammation Mediators

Autor:innen und Institutionen

  • From the Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (C.H., C.L., L.H.L.); Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden (C.H., C.L., L.H.L.); Cardiovascular and…

Zitieren

APA

Hage, C., Michaëlsson, E., Linde, C., Donal, E., Daubert, J. C., Gan, L. M., & Lund, L. H. (2017). Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction. Circulation: Cardiovascular Genetics, 10(1). https://doi.org/10.1161/circgenetics.116.001633

Vancouver

Hage C, Michaëlsson E, Linde C, Donal E, Daubert JC, Gan LM, et al. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction. Circulation: Cardiovascular Genetics. 2017;10(1). doi:10.1161/circgenetics.116.001633

BibTeX
@article{Hage2017,
  author = {Hage, Camilla and Michaëlsson, Erik and Linde, Cecilia and Donal, Erwan and Daubert, Jean-Claude and Gan, Li-Ming and Lund, Lars H},
  title = {Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction},
  journal = {Circulation: Cardiovascular Genetics},
  year = {2017},
  volume = {10},
  number = {1},
  doi = {10.1161/circgenetics.116.001633}
}
Kostenlos starten →